TRDA R&D Expense Growth
Entrada Therapeutics Inc · R&D Expense Growth
TRDA R&D Expense Growth
Latest reported13.54%period ending
TRDA FY R&D Growth (YoY) (0.00% → 13.54%)
Latest values, visible window
High-resolution chart · PNG
TRDA r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 13.5373% | |
| 25.4515% | |
| 49.9557% | |
| 85.4061% | |
| 70.2493% | |
| 156.8403% | |
| 0% |